Pullback in Coronavirus Stocks Provide More Reasonable Entry Points

Alerts

(NEW YORK)–Coronavirus stocks pulled back offering more reasonable entry points as US cases continue to spread.

Coronavirus stocks saw a sharp pullback from there recent highs on Tuesday. Reasons for this were that many traders were using COVD-19 stocks as sort of “puts” or safe havens on the broader market, and took profits as market stablized. In addition, many found sellers based on oversold indicators such as RSI on these charts.

Ludlow Research made note to subscribers that some popular coronavirus plays pulled backed anywhere from 20% to 30% Tuesday, which may now offer a more attractive reentry level for traders.

They made point that stocks have now dropped below “overbought” levels, which are usually indicated with RSI of 70 or higher, and could indicate a good time to step back in.

The other aspect made was that this virus outbreak isn’t going to end near-term so the catalyst that fueled these prior rallies still remain intact.

Recent Developments in Coronavirus

– NY Deploys national Guard in Westchester, NY
– Schools closing, colleges going to online only classes
– Conferences being cancelled
– US deaths now 28, new cases expected to climb
– Government funding expected

Some coronavirus stocks on Ludlow Research watch are:

AIM ImmunoTech (NYSE:AIM), which recently submitted vaccine to japan’s National Institutes of Health – $4.20

OPKO Health (NASDAQ:OPK) which is developing test kits for coronavirus, which are in dire shortage nationwide currently. – $1.60

Heat Biologics (NASDAQ: HTBX) which has collaboration deal with University of Miami to develop a vaccine. – $0.62

Ibio Inc (NYSE:IBIO), which provides technology for rapid production of potential vaccines for coronavirus – $1.41

Cocrystal Pharma (NASDAQ: COCP), which is developing antiviral compounds for treatment of Coronavirus using proprietary drug discovery platform – $1.14


These are developing stories – if you would like to get an updated opinion on these and other coronavirus stocks register to our newsletter at
https://wallstreetnewscast.com/sectors/coronavirus/

Ludlow Research is a New York based equity research firm that focuses on providing research coverage and investor awareness services to emerging small-cap companies. For over 12 years we have worked to provide our readers with a simple way of evaluating the current and potential value of small-cap companies. For more information please visit www.ludlowresearch.com

Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. In Compliance with SEC Rule 17B WSNC was not compensated for this media alert. WSNC, or any of its affiliates, hold no positions in securities mentioned above. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial adviser before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial adviser before making any and all investment decisions when investing in these type of securities

Share